Publicacións en colaboración con investigadores/as de Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (6)

2018

  1. Immunogenicity and safety of measles-mumps-rubella vaccine at two different potency levels administered to healthy children aged 12-15 months: A phase III, randomized, non-inferiority trial

    Vaccine, Vol. 36, Núm. 38, pp. 5781-5788

2013

  1. Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain

    Vaccine, Vol. 31, Núm. 46, pp. 5486-5494

  2. Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule

    Vaccine, Vol. 31, Núm. 42, pp. 4765-4774

  3. The impact of atmospheric pollutants on the prevalence of atopic eczema in 6-7-year-old schoolchildren in Spain; ISAAC phase III

    Iranian Journal of Allergy, Asthma and Immunology, Vol. 12, Núm. 3, pp. 220-227

2012

  1. Safety of a 2-dose regimen of a combined measles, mumps, rubella and varicella live vaccine manufactured with recombinant human albumin

    Pediatric Infectious Disease Journal, Vol. 31, Núm. 11, pp. 1166-1172

2011

  1. Circovirus and impact of temporary withdrawal of rotavirus vaccines in Spain

    HUMAN VACCINES